Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cardioplexol versus Buckberg solution in elective cardiac surgery with cardiopulmonary bypass
2011-004198-10Phase 3Completed
- Sponsor
- Swiss Cardio Technologies
- Start
- Oct 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, single-blind trial of Cardioplexol in coronary arteriosclerosis (2 arms), sponsored by Swiss Cardio Technologies. Primary endpoint: Maximum troponin-T in first 24 hours after myocardial reperfusion. Started Oct 2011; status: completed.
02
Drugs
Cardioplexol
03
Conditions
coronary arteriosclerosis
Beyond the preview
Go deeper on 2011-004198-10.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2011-004198-10.